Perils at mucosal front lines for HIV and SIV and their hosts
- PMID: 16200081
- DOI: 10.1038/nri1706
Perils at mucosal front lines for HIV and SIV and their hosts
Abstract
HIV-1 and simian immunodeficiency virus (SIV), as well as their hosts, face perils at mucosal front lines in early infection. At these sites, 'resting' CD4+ memory T cells fuel infection (because they are hosts for virus), depleting CD4+ memory T cells throughout the lymphoid tissues, particularly in the gut, and eliciting an immunosuppressive regulatory T-cell response that impairs host defence. But HIV-1 and SIV also risk elimination at the earliest stage of infection, at the mucosal point of entry, if founder populations of infected cells do not expand sufficiently to establish a self-propagating infection. Microbicides and vaccines could increase these viral vulnerabilities at mucosal front lines.
Similar articles
-
Targeting early infection to prevent HIV-1 mucosal transmission.Nature. 2010 Mar 11;464(7286):217-23. doi: 10.1038/nature08757. Nature. 2010. PMID: 20220840 Review.
-
Mucosal immune dysfunction in AIDS pathogenesis.AIDS Rev. 2008 Jan-Mar;10(1):36-46. AIDS Rev. 2008. PMID: 18385779 Review.
-
Lymphatic Dissemination of Simian Immunodeficiency Virus after Penile Inoculation.J Virol. 2016 Mar 28;90(8):4093-4104. doi: 10.1128/JVI.02947-15. Print 2016 Apr. J Virol. 2016. PMID: 26865706 Free PMC article.
-
Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction.J Virol. 2017 Nov 14;91(23):e01051-17. doi: 10.1128/JVI.01051-17. Print 2017 Dec 1. J Virol. 2017. PMID: 28931679 Free PMC article.
-
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.Nature. 2005 Apr 28;434(7037):1148-52. doi: 10.1038/nature03513. Nature. 2005. PMID: 15793562
Cited by
-
Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.Vaccine. 2007 Mar 8;25(12):2187-93. doi: 10.1016/j.vaccine.2006.11.044. Epub 2006 Dec 6. Vaccine. 2007. PMID: 17229501 Free PMC article.
-
Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissues.PLoS Comput Biol. 2010 Sep 2;6(9):e1000906. doi: 10.1371/journal.pcbi.1000906. PLoS Comput Biol. 2010. PMID: 20824126 Free PMC article.
-
HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection?PLoS Pathog. 2008 Aug 29;4(8):e1000114. doi: 10.1371/journal.ppat.1000114. PLoS Pathog. 2008. PMID: 18769723 Free PMC article. Review. No abstract available.
-
Differential compartmentalization of HIV-targeting immune cells in inner and outer foreskin tissue.PLoS One. 2014 Jan 15;9(1):e85176. doi: 10.1371/journal.pone.0085176. eCollection 2014. PLoS One. 2014. PMID: 24454812 Free PMC article.
-
Functional implications of the binding mode of a human conformation-dependent V2 monoclonal antibody against HIV.J Virol. 2014 Apr;88(8):4100-12. doi: 10.1128/JVI.03153-13. Epub 2014 Jan 29. J Virol. 2014. PMID: 24478429 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials